Navigation Links
Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer
Date:2/15/2011

SAN JOSE, Calif., Feb. 15, 2011 /PRNewswire/ -- Baxano, Inc. (www.baxano.com) today announced the addition of George A. Harter, Jr. to the executive team at Baxano, Inc. As Chief Financial Officer, Mr. Harter will be responsible for Finance, Administration and Human Resources.

Mr. Harter served as the Chief Financial Officer for Acclarent, Inc. from 2005 to 2011, through its acquisition by Johnson & Johnson. From September 2003 to April 2005, Mr. Harter served as Chief Financial Officer for Velocimed, an interventional cardiology company. Prior to Velocimed, Mr. Harter held roles at other health care companies including Boston Scientific. Mr. Harter received his B.A. in Economics from the University of California, Los Angeles and his M.B.A. from Case Western Reserve University.

"George is a key senior executive hire who adds tremendous credibility to our already strong team," said Tony Recupero, President and CEO of Baxano, Inc.  "In 2011, our focus on will be on rapidly growing our base of clinical experience. With his impressive background establishing and growing financial and operational systems, he will play a key role in our continuing full commercial launch of the iO-Flex System."

"Baxano's less invasive iO-Flex™ System holds great promise for many patients suffering from spinal stenosis and provides a cost-effective treatment alternative to health care providers and insurers. I am excited to join Baxano as they bring this compelling technology to market and look forward to leveraging my experience to build another robust commercial-stage medical device company," said Mr. Harter.

About Baxano, Inc.

Based in San Jose, CA, Baxano, Inc., (www.BAXANO.com) is focused on developing innovative solutions that restore spine function, preserve healthy tissue, and enable a better quality of life for patients. Baxano, Inc. is the developer of the iO-Flex™ System which is an advancement in surgical technology for central, lateral recess and foraminal lumbar stenosis. This unique technology uses thin, flexible instruments through an open exposure or a minimally invasive tube to provide precision lumbar decompression from the "inside out" ("iO"). This "over the wire" approach allows surgeons to address targeted impinging tissue with a non-implant, direct decompression, while preserving facet joint integrity.  Up to four nerve roots may be decompressed through a single-point access using this system.

Note: Baxano™ and iO-Flex™ are trademarks and service marks of Baxano, Inc.


'/>"/>
SOURCE Baxano, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards
2. Baxano, Inc. Announces Close of $30 Million Series C Funding
3. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
4. Access MediQuip Names Prakash Patel Chief Executive Officer
5. CareFusion Names Kieran T. Gallahue Chairman and CEO
6. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
7. Cetero Research Names Dr. Roger Hayes President of Bioanalytical Operations
8. Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
9. MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area
10. Topaz Pharmaceuticals Names Dr. Mark Strobeck Chief Business Officer
11. West Names New President of Pharmaceutical Packaging Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
Breaking Medicine News(10 mins):